Liaoning Heshi Ophthalmic Hospital Group Co., Ltd
Initial public offering and listing on GEM
Announcement on online subscription and winning rate
Sponsor (lead underwriter): Central China Securities Co.Ltd(601375)
The application of Liaoning Heshi ophthalmology hospital group Co., Ltd. (hereinafter referred to as "Heshi ophthalmology" or "the issuer") for the initial public offering of RMB common shares (A shares) (hereinafter referred to as "this offering") and listing on the gem has been examined and approved by the GEM Listing Committee of Shenzhen Stock Exchange (hereinafter referred to as "Shenzhen Stock Exchange"), It has been approved to register by China Securities Regulatory Commission (hereinafter referred to as "CSRC") (zjxk [2022] No. 126).
The issuer negotiated with the sponsor (lead underwriter) Central China Securities Co.Ltd(601375) (hereinafter referred to as " Central China Securities Co.Ltd(601375) " or "sponsor (lead underwriter)") to determine the number of shares to be issued this time is 30.5 million shares, and the issue price is 42.50 yuan / share. The issuing price of this offering shall not exceed the median and weighted average of offline investors' quotation after excluding the highest quotation, as well as the securities investment fund, national social security fund, basic old-age insurance fund established through public offering after excluding the highest quotation The enterprise annuity fund established in accordance with the measures for the administration of enterprise annuity fund and the insurance fund quotation median and weighted average in accordance with the measures for the administration of the use of insurance funds, whichever is lower.
According to the issuing price, the relevant subsidiaries of the sponsor will not participate in the strategic placement. Finally, this issuance will not be targeted to strategic investors. The difference between the initial strategic placement and the final strategic placement was 1525000 shares, which were transferred back to offline issuance.
This issuance is finally carried out through the combination of offline inquiry and placement to qualified investors (hereinafter referred to as "offline issuance") and online pricing issuance to social public investors holding non restricted A-share shares and non restricted depositary receipts market value in Shenzhen market (hereinafter referred to as "online issuance").
After the strategic placement call back and before the online and offline call back mechanism was launched, the initial number of offline shares was 218075 million, accounting for 71.50% of the number of shares issued this time; The initial number of shares issued online was 8.6925 million, accounting for 28.50% of the number issued this time. The total number of final offline and online issuance is 30.5 million shares, and the final number of online and offline issuance will be determined according to the call back situation.
On March 10, 2022 (t day), the issuer initially issued 8692500 shares of "he ophthalmology" by using the online pricing of the trading system of Shenzhen Stock Exchange (hereinafter referred to as "Shenzhen Stock Exchange").
Please pay attention to the payment link of this offering and fulfill the payment obligation on March 14, 2022 (T + 2):
1. According to the announcement on the initial public offering of shares by Liaoning Heshi Ophthalmic Hospital Group Co., Ltd. and the preliminary placement results of offline issuance listed on the gem, the offline allocated investors shall pay the subscription funds for new shares in time and in full according to the finally determined issuance price and allocated quantity before 16:00 on March 14 (T + 2) 2022.
The subscription funds shall be paid in full within the specified time. If the subscription funds are not paid in full within the specified time or as required, all the new shares allocated to the placing object shall be invalid. If there are more than one new shares to be issued on the same day, all of them will be invalid. If different placing objects share bank accounts, if the subscription funds are insufficient, all the new shares allocated to the placing objects sharing bank accounts will be invalid. Offline investors are allocated multiple new shares on the same day. Please pay for each new share separately.
After the online investors win the lot in the subscription of new shares, they shall fulfill the obligation of capital delivery in accordance with the announcement on the results of initial public offering of shares by Liaoning Heshi Ophthalmic Hospital Group Co., Ltd. and online lottery for listing on the gem, so as to ensure that their capital account will eventually have sufficient capital for the subscription of new shares on March 14 (T + 2) 2022, and the insufficient part shall be deemed to have given up the subscription, The resulting consequences and relevant legal liabilities shall be borne by the investors themselves. The transfer of investors' funds shall comply with the relevant provisions of the securities company where the investors are located.
The shares abandoned by offline and online investors shall be underwritten by the sponsor (lead underwriter).
2. Among the stocks issued this time, the stocks issued online have no circulation restrictions and limited sales period arrangements, and can be circulated from the date when the stocks issued this time are listed on the Shenzhen Stock Exchange.
The offline issuance part adopts the proportional sales restriction method, and the offline investors shall promise that the sales restriction period of 10% (rounded up) of the number of shares allocated to them is 6 months from the date of the issuer's initial public offering and listing. That is, among the shares allocated to each placing object, 90% of the shares are sold indefinitely and can be circulated from the date when the issued shares are listed and traded on the Shenzhen Stock Exchange; The sales restriction period of 10% of the shares is 6 months, and the sales restriction period starts from the date when the issued shares are listed and traded on the Shenzhen Stock Exchange.
When offline investors participate in the preliminary inquiry and quotation and offline purchase, they do not need to fill in the arrangement of the restricted sale period for the placing objects under their management. Once the quotation is made, it is deemed to accept the arrangement of the online restricted sale period disclosed in this announcement.
3. When the total number of shares paid and subscribed by offline and online investors is less than 70% of the number of public offerings, the issuer and the sponsor (lead underwriter) will suspend the issuance of new shares and disclose the reasons for the suspension and subsequent arrangements.
4. If the offline investors who provide effective quotation fail to participate in the subscription or obtain the preliminary placement and fail to pay the subscription amount in time and in full, it will be deemed as a breach of contract and shall bear the liability for breach of contract. The recommendation institution (lead underwriter) shall report the breach of contract to the China Securities Association for the record. The number of violations of placing objects in various sectors of the stock market of Beijing stock exchange (hereinafter referred to as "Beijing stock exchange"), Shanghai Stock Exchange (hereinafter referred to as "Shanghai Stock Exchange") and Shenzhen Stock Exchange shall be calculated together. During the period of being included in the restricted list, the placing object shall not participate in the offline inquiry and placement of relevant projects in all sectors of the stock market of Beijing stock exchange, Shanghai Stock Exchange and Shenzhen Stock Exchange.
If online investors fail to pay in full after winning the lottery for three times in a row within 12 months, they shall not participate in the online subscription of new shares, depositary receipts, convertible corporate bonds and exchangeable corporate bonds within 6 months (calculated as 180 natural days, including the next day) from the next day of the settlement participant's latest declaration of abandonment of subscription.
The number of times of giving up subscription shall be calculated according to the number of times of investors actually giving up subscription of new shares, depositary receipts, convertible corporate bonds and exchangeable corporate bonds.
1、 Online subscription
According to the data provided by Shenzhen Stock Exchange, the sponsor (lead underwriter) has made statistics on the subscription of this online offering. The number of effective subscription accounts of this online offering is 12691279, the number of effective subscription shares is 84203722000, the total number of allotments is 168407444, the starting number of allotments is 000000 Ping An Bank Co.Ltd(000001) , and the ending number is 000168407444.
2、 Implementation of callback mechanism, issuance structure and success rate of online issuance
According to the callback mechanism announced in the announcement of Liaoning Heshi Ophthalmic Hospital Group Co., Ltd. on initial public offering and listing on the gem, the issuer and the sponsor (lead underwriter) decided to start the callback mechanism because the initial effective subscription multiple on the Internet was 968693955 times, higher than 100 times, 20% (6.1 million shares) of the shares issued this time will be transferred back from offline to online.
After the call back, the final number of offline shares issued was 157075 million, accounting for 51.50% of the total issued this time; The final number of shares issued online was 14792500, accounting for 48.50% of the total issued this time. After the call back, the winning rate of this online offering was 00175675132%, and the subscription multiple was 569232530 times.
3、 Online lottery
The sponsor (lead underwriter) and the issuer will conduct lottery in Room 202, building 203, Shangbu Industrial Zone, Hongli West Road, Futian District, Shenzhen on the morning of March 11, 2022 (T + 1), and will publish the lottery results in China Securities News, Shanghai Securities News, securities times, securities daily and economic reference online on March 14, 2022 (T + 2).
Issuer: Liaoning Heshi Ophthalmic Hospital Group Co., Ltd
Sponsor (lead underwriter) Central China Securities Co.Ltd(601375)
March 11, 2022
(there is no text on this page, which is the seal page of the announcement on the online subscription and winning rate of Liaoning Heshi Ophthalmic Hospital Group Co., Ltd. for its initial public offering and listing on the GEM)
Issuer: Liaoning Heshi Ophthalmic Hospital Group Co., Ltd. (no text on this page, which is the seal page of the announcement on the online subscription and winning rate of Liaoning Heshi Ophthalmic Hospital Group Co., Ltd. for its initial public offering of shares and listing on the GEM)
Sponsor (lead underwriter): Central China Securities Co.Ltd(601375) mm / DD / yyyy
